n the largest penalty of its kind involving a drug maker, Teva Pharmaceutical agreed to pay more than $519 million to settle civil and criminal charges of violating the Foreign Corrupt Practices Act for bribing foreign government officials in Russia, Ukraine, and Mexico.

Federal authorities alleged that Teva made more than $214 million in illicit profits by making “influential payments” to increase its market share and win regulatory and formulary approvals, as well as favorable drug purchases and prescriptions written by health care providers.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Recommended Stories

Pharmaceutical production
Drug Pricing

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.